Notifications
2014_09_02 Data Snapshot
Table 1. Get Full Table
| Barcode | UUID | Date | Type | Category | Notes |
|---|---|---|---|---|---|
| TCGA-18-3406 | 95b83006-02c9-4c4d-bf84-a45115f7d86d | 10/31/2012 | LUSC | Prior malignancy | Prior malignancy L LUSC. No systemic chemotherapy or radiation. |
| TCGA-18-3407 | 4e1ad82e-23c8-44bb-b74e-a3d0b1126b96 | 10/31/2012 | LUSC | Prior malignancy | Prior malignancy R tongue treated with radiation. |
| TCGA-18-3407 | 4e1ad82e-23c8-44bb-b74e-a3d0b1126b96 | 11/10/2012 | LUSC | History of acceptable prior treatment related to a prior/other malignancy | Prior malignancy R tongue treated with radiation. |
| TCGA-18-3409 | b09e872a-e837-49ec-8a27-84dcdcabf347 | 10/31/2012 | LUSC | Prior malignancy | Prior malignancy basal cell carcinoma of the forehead. No systemic chemotherapy or radiation. Prior malignancy basaloid squamous cell carcinoma of the anal canal treated with chemotherapy and radiation. |
| TCGA-18-3409 | b09e872a-e837-49ec-8a27-84dcdcabf347 | 11/10/2012 | LUSC | History of unacceptable prior treatment related to a prior/other malignancy | Prior malignancy basal cell carcinoma of the forehead. No systemic chemotherapy or radiation. Prior malignancy basaloid squamous cell carcinoma of the anal canal treated with chemotherapy and radiation. |
| TCGA-18-3410 | 99599b60-4f5c-456b-8755-371b1aa7074e | 10/31/2012 | LUSC | Prior malignancy | Prior malignancy squamous cell carcinoma of the foot. No systemic chemotherapy or radiation. |
| TCGA-18-3416 | 6eb61cab-8e83-4c18-a59a-ae0985ec9d2e | 10/31/2012 | LUSC | Prior malignancy | Prior malignancy melanoma of the left chest. Prior malignancy melanoma of the arm. Unknown treatment history. |
| TCGA-18-4083 | a33f0741-2161-4818-89f2-ec8ccae57949 | 11/10/2012 | LUSC | Synchronous malignancy | Pt with synchronous malignancy of the larynx. |
| TCGA-18-4721-01A-21-2193-20 | 980eebae-fe8b-4121-8744-92b2448cb72b | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-18-5592-01A-21-2194-20 | faeb872c-4711-4218-a772-c660855358f7 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-18-5595 | 628b1bc3-825b-4d0e-a4cd-57eeaf98e798 | 10/31/2012 | LUSC | Prior malignancy | Prior malignancy cancer of the pharynx treated with cisplatin. |
| TCGA-18-5595 | 628b1bc3-825b-4d0e-a4cd-57eeaf98e798 | 11/10/2012 | LUSC | History of unacceptable prior treatment related to a prior/other malignancy | Prior malignancy cancer of the pharynx treated with cisplatin. |
| TCGA-18-5595-01A-21-2194-20 | cf74338e-67f3-4979-a898-8a8c20bc9485 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-21-1070 | 28f899c5-ea17-4df6-83e6-e744e04d0ea1 | 11/10/2012 | LUSC | History of unacceptable prior treatment related to a prior/other malignancy | Prior malignancy breast cancer treated with chemo and radiation per path report |
| TCGA-21-1070 | 28f899c5-ea17-4df6-83e6-e744e04d0ea1 | 12/06/2010 | LUSC | Prior malignancy | [intgen.org]: Subject has Hx of prior malignancy |
| TCGA-21-1070-01A-21-2193-20 | c31cbb43-8115-476d-94eb-969f05a749ce | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-21-1071-01A-21-2193-20 | d9fa8294-49b1-4474-bbfb-ffdf6d807382 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-21-1072-01A-21-2193-20 | 7ba5ebaa-df07-4f54-8721-67523cfddc60 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-21-1075-01A-21-2193-20 | 11303d09-57ac-4b08-a3a4-efddc42857a3 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-21-1076-01A-01D | 74916ee7-3546-426a-be7c-5826733a8cbd | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 70-80% |
| TCGA-21-1076-01A-01R | 708fea2e-607d-4221-9525-2828d05365ff | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 70-80% |
| TCGA-21-1076-01A-01T | e9b5e920-a384-4f4d-93f3-c286c40e0e3a | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 70-80% |
| TCGA-21-1076-01A-41-2193-20 | 865ca095-4591-4ca4-8237-a31e6481ccca | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-21-1076-11A-01D | 2d534fea-6b06-4adc-9bc2-100e8c633a91 | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 70-80% |
| TCGA-21-1077 | f516991c-5139-4b3e-b605-5a3d90688209 | 06/16/2014 | LUSC | History of unacceptable prior treatment related to a prior/other malignancy | unknown treatment history |
| TCGA-21-1077 | f516991c-5139-4b3e-b605-5a3d90688209 | 12/06/2010 | LUSC | Prior malignancy | [intgen.org]: Subject has Hx of prior malignancy |
| TCGA-21-1078 | 0ab8d063-62b4-4d47-82aa-e3351a60029d | 06/16/2014 | LUSC | History of unacceptable prior treatment related to a prior/other malignancy | unknown treatment history |
| TCGA-21-1078 | 0ab8d063-62b4-4d47-82aa-e3351a60029d | 12/06/2010 | LUSC | Prior malignancy | [intgen.org]: Subject has Hx of prior malignancy |
| TCGA-21-1078-01A-21-2193-20 | 7c470e40-177f-45c5-96bc-e826294882c5 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-21-1079-01A-01D | decf0d88-0cbe-4cca-bda6-e0558dee0e1d | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 70-80% |
| TCGA-21-1079-01A-01R | b11ed052-fc60-4793-b925-829a5b092901 | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 70-80% |
| TCGA-21-1079-01A-01T | a4d1337e-54a9-4f41-a3eb-42f9fd9ed07e | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 70-80% |
| TCGA-21-1079-01A-21-2193-20 | 9af4adc0-d07e-4e5d-a656-cfb61bfa2c82 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-21-1079-11A-01D | abf21454-3866-4f6a-a165-f9993004f43d | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 70-80% |
| TCGA-21-1080-01A-21-2193-20 | 19c9ff90-4114-44a5-97be-310997f17334 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-21-1081 | 2afa2fd8-e4d9-4e7b-b387-7e2451764d5d | 09/02/2010 | LUSC | Molecular analysis outside specification | [intgen.org]: Molecular Results off Spec |
| TCGA-21-1081-01A-21-2193-20 | 2d90e6b8-02bf-4665-9803-285243e1ba55 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-21-1082-01A-21-2193-20 | cc44dbbd-5a78-4440-82b5-a2c2d6ef4d7c | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-21-1083 | 0398eae1-7216-4595-80a5-6b117d96e070 | 06/16/2014 | LUSC | History of unacceptable prior treatment related to a prior/other malignancy | unknown treatment history |
| TCGA-21-1083 | 0398eae1-7216-4595-80a5-6b117d96e070 | 12/06/2010 | LUSC | Prior malignancy | [intgen.org]: Subject has Hx of prior malignancy |
| TCGA-21-1083-01A-21-2193-20 | 3e8610c1-5e34-4ea1-ad30-37225b06e71a | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-21-5782-01A-21-2194-20 | 5ad0c478-996f-4211-a829-ff7b0fec72d2 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-21-5784-01A-21-2194-20 | 29d0b45f-ad9b-49a7-af41-979364bc1728 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-21-5786-01A-21-2194-20 | 98c3c72d-b20b-400d-a53e-8e7d24c3e79a | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-21-5787-01A-21-2194-20 | 37941bbd-aee2-4a9d-891a-a0aa0e8c7714 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-21-A5DI | a7cd7b0f-ab76-4f3f-a2d5-5ec04fe6c4f3 | 06/16/2014 | LUSC | History of unacceptable prior treatment related to a prior/other malignancy | unknown treatment history |
| TCGA-22-0940-01A-21-2193-20 | 3d8cb3f0-482e-4acd-bb89-e8530456cd3c | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-22-0944-01A-01D | aba91c63-0dbf-43aa-a165-7edcf8a634b4 | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 60-70% |
| TCGA-22-0944-01A-01R | bfdf791f-80ce-45bb-8731-377c6da15a7e | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 60-70% |
| TCGA-22-0944-01A-01T | 96553d0a-d94a-46ac-9ae2-3856ec5c56b1 | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 60-70% |
| TCGA-22-0944-11A-01D | 8b1ba57c-fdd5-4f80-b88e-0088145c3227 | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 60-70% |
| TCGA-22-1000 | 972476b7-d7f3-4865-b978-0c13f29457cb | 11/10/2012 | LUSC | History of acceptable prior treatment related to a prior/other malignancy | Prior malignancy prostate cancer treated w/ radation |
| TCGA-22-1000 | 972476b7-d7f3-4865-b978-0c13f29457cb | 12/06/2010 | LUSC | Prior malignancy | [intgen.org]: Subject has Hx of prior malignancy |
| TCGA-22-1000-01A-01D | 4f7bc702-52de-40c3-976c-2accc0a879eb | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 60-70% |
| TCGA-22-1000-01A-01R | ac1860cc-17c6-49ac-8b0b-0ac1d0c455e9 | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 60-70% |
| TCGA-22-1000-01A-01T | d20150a8-bfb8-49c2-9ca7-4433bfca10a3 | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 60-70% |
| TCGA-22-1000-01A-21-2193-20 | 10ac4555-d3e6-4d70-a6ca-2253c0e92de1 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-22-1000-11A-01D | 70ea4fc2-f84f-43ea-9235-5a0748814cf8 | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 60-70% |
| TCGA-22-1002-01A-01D | 28b912af-a630-4219-9aa1-d479508b0cc0 | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 60-70% |
| TCGA-22-1002-01A-01R | 4dae830c-a6cc-403b-b259-c9ef7179f7d4 | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 60-70% |
| TCGA-22-1002-01A-01T | f2402c60-3d82-4053-a1a3-58a49b4302d1 | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 60-70% |
| TCGA-22-1002-11A-01D | bc226b91-5b76-498e-94f1-64619b7e3e2b | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 60-70% |
| TCGA-22-1005-01A-01D | 579db5ec-b747-4435-9534-280e7aeb897a | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 60-70% |
| TCGA-22-1005-01A-01R | 9956ae45-ab62-4658-8df7-2df905a7b11d | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 60-70% |
| TCGA-22-1005-01A-01T | b2dbcf54-2c0f-4f22-98c0-4a490e307033 | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 60-70% |
| TCGA-22-1005-11A-01D | 509098f4-d589-4664-a4d8-6f4fbf98ffdf | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 60-70% |
| TCGA-22-1011-01A-01D | 9de5f031-6c27-4048-b49e-591e8ea7e1fa | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 60-70% |
| TCGA-22-1011-01A-01R | 07c9892c-5f7c-412f-9e47-8b47d1db4c2b | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 60-70% |
| TCGA-22-1011-01A-01T | bd049a35-5bf8-463f-9237-b84e45eda038 | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 60-70% |
| TCGA-22-1011-01A-31-2193-20 | fcc5d2fc-0775-4e47-9ded-959aba2b92f5 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-22-1011-11A-01D | f17e14d2-ea96-456c-a307-455983c2e162 | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 60-70% |
| TCGA-22-1012-01A-01D | 3d3d7a9e-5719-4593-b6e4-e68343b88a3f | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 70-80% |
| TCGA-22-1012-01A-01R | 0b18e84c-4bb6-4d81-99ac-bf43c351fc26 | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 70-80% |
| TCGA-22-1012-01A-01T | 7c063a26-71e9-4eea-8867-f1732d922fe6 | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 70-80% |
| TCGA-22-1012-11A-01D | 0e36ccf2-8a55-4996-86f3-993ea39c90d7 | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 70-80% |
| TCGA-22-1016-01A-01D | e364ac31-ea3c-4f5f-b136-8bf1dcb9e99a | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 60-70% |
| TCGA-22-1016-01A-01R | 6fd3e50d-b815-4e83-a951-6cebec8bbf38 | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 60-70% |
| TCGA-22-1016-01A-01T | 87c0463e-91e8-4850-b871-1d063d6ebbb7 | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 60-70% |
| TCGA-22-1016-11A-01D | 0623e8e7-a885-4c79-82f7-385be4d5f7bc | 03/14/2011 | LUSC | Item is noncanonical | Lung Squamous Cell Carcinoma 60-70% |
| TCGA-22-1017 | 25f64b80-0672-4980-9875-956b1699309b | 09/02/2010 | LUSC | Neoadjuvant therapy | [intgen.org]: Subject Positive for Neo-Adjuvant Therapy |
| TCGA-22-1017 | 25f64b80-0672-4980-9875-956b1699309b | 10/31/2012 | LUSC | Prior malignancy | Prior malignancy and neo-adjuvant treatment per enrollment form. |
| TCGA-22-1017 | 25f64b80-0672-4980-9875-956b1699309b | 11/10/2012 | LUSC | Neoadjuvant therapy | Prior malignancy and neo-adjuvant treatment per enrollment form. |
| TCGA-22-4591-01A-21-2193-20 | 5be370a5-e710-4625-8781-43856b8e39af | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-22-4596-01A-21-2194-20 | 4f5b1160-c56c-4696-90a5-2dffc0569b5f | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-22-4605-01A-11-2193-20 | 5e7c3893-5bf5-4bbb-a98f-ea293538f5ff | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-22-4607-01A-21-2194-20 | 79c272f1-478c-4a0a-845f-ba113df49b55 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-22-4609-01A-11-2193-20 | f445dc4e-7f34-47ee-98d7-7f9586084719 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-22-5471 | bece6b8e-5d6c-4dd6-85a3-9b3a9c670aa7 | 10/31/2012 | LUSC | Prior malignancy | Prior malignancy melanoma of the neck. No systemic chemotherapy or radiation. |
| TCGA-22-5471-01A-21-2194-20 | 43c5c2ec-d9a9-4fa2-8f12-fa74a31d2e3f | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-22-5472 | bd3bf142-7c14-4538-8a76-3c6e140fa01a | 10/31/2012 | LUSC | Prior malignancy | Prior malignancy SCC of the L cheek. No systemic chemotherapy or radiation. |
| TCGA-22-5472-01A-21-2194-20 | 61b44402-a6de-458c-9d45-4b4c258b1590 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-22-5473-01A-21-2194-20 | a79a1a5c-7c23-4c61-9e70-6f1e6c1f5317 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-22-5474-01A-21-2194-20 | 78ec1e12-ed4e-44f3-abb8-aff8b543e2d1 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-22-5477-01A-21-2194-20 | 5162d956-a988-4b03-ae52-d57aa76b1025 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-22-5478-01A-21-2194-20 | 7554f5f0-1c1a-4f71-9d7a-836266435c78 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-22-5479-01A-11-2194-20 | 78c6397c-c479-4743-af4b-61c1bbdc4d3f | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-22-5480-01A-21-2194-20 | 52b7abd6-8f9d-4aac-bb99-f0f2c596dac8 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-22-5482-01A-21-2194-20 | 2536d089-b6cf-464e-bd43-9c97b0d8948f | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-22-5483-01A-21-2194-20 | 6ff0360e-5a35-4886-8277-c2883374ebb0 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-22-5485-01A-21-2194-20 | 74b2de24-102f-449b-bbf8-ed2e5aaedb63 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-22-5489-01A-21-2194-20 | 04508643-b5be-4165-9d6e-4f3687afdfd7 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-22-5491-01A-21-2194-20 | 82d12699-72d1-4283-b45e-35680eb3670b | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-22-5492-01A-21-2194-20 | d68eb7ee-e5c5-413b-973b-82cf3ae37d55 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-33-4532 | 6ee6ca0a-8702-480d-b2d1-9224e7dd9211 | 10/31/2012 | LUSC | Prior malignancy | Prior malignancy of the lip and nose. No systemic chemotherapy or radiation. |
| TCGA-33-4532-01A-21-2193-20 | 145f9405-fb5b-432d-8928-063e0d3a7b43 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-33-4533 | b4ff0f49-b787-48ec-91cc-ee26786ff1bf | 10/31/2012 | LUSC | Prior malignancy | Prior malignancy L LUSC. No systemic chemotherapy or radiation. |
| TCGA-33-4538 | c70a5975-c37b-47cc-9113-427a754807d8 | 11/10/2012 | LUSC | Neoadjuvant therapy | Patient received neo-adjuvant treatment prior to resection of TCGA tumor per enrollment form. |
| TCGA-33-4547-01A-21-2193-20 | 843b8ba9-57ff-4db6-98fb-1c2a508f98b7 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-33-4566-01A-21-2193-20 | 585632a4-48ad-4dda-89f6-c6ad289305f0 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-33-4579 | 1169b8c3-e5ae-47a8-91db-0ce62a5958e2 | 10/31/2012 | LUSC | Prior malignancy | Prior malignancy SCC of the nasal cavity. No systemic chemotherapy or radiation. |
| TCGA-33-4582-01A-21-2193-20 | f6afdaa8-47c3-4483-9a13-62fdc67f4c16 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-33-4586-01A-21-2193-20 | c153a3c3-eaff-4a5b-b4fd-dc4d467669e7 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-33-4589 | 49f975ea-a1cf-4a9b-bf13-030c68cc99e4 | 10/31/2012 | LUSC | Prior malignancy | Prior malignancy SCC of the tongue treated with locoregional radiation. |
| TCGA-33-4589 | 49f975ea-a1cf-4a9b-bf13-030c68cc99e4 | 11/10/2012 | LUSC | History of acceptable prior treatment related to a prior/other malignancy | Prior malignancy SCC of the tongue treated with locoregional radiation. |
| TCGA-33-4589-01A-21-2193-20 | 78114d62-a9cb-4bfa-8c47-a84e9c53802f | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-33-6737 | afedf3fb-fc77-45a7-bdcd-2c78706a0f8a | 11/10/2012 | LUSC | History of unacceptable prior treatment related to a prior/other malignancy | Prior malignancy Hairy Cell Leukemia treated with 2-CdA and Pentostatin. |
| TCGA-33-6737 | afedf3fb-fc77-45a7-bdcd-2c78706a0f8a | 11/18/2011 | LUSC | Prior malignancy | [intgen.org]: Subject has Hx of prior malignancy |
| TCGA-33-6737-01A-13-2194-20 | f15f6e1d-a3f0-4de4-9060-833a3989022f | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-33-6738-01A-13-2194-20 | 5dcec6e8-27e0-4674-b842-8f2d2542d907 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-34-2596-01A-21-2193-20 | 9d1b859e-95d7-43d1-b71a-c0a0c240ccda | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-34-2604 | cee6e9f6-6d7e-4096-a9bc-2cce004fb218 | 09/02/2010 | LUSC | Prior malignancy | [intgen.org]: Prior Malignancy |
| TCGA-34-2604 | cee6e9f6-6d7e-4096-a9bc-2cce004fb218 | 11/10/2012 | LUSC | History of acceptable prior treatment related to a prior/other malignancy | Prior malignancy bladder cancer treated w/ locoregional radiation. |
| TCGA-34-2604-01A-21-2193-20 | cf27663d-6ff3-4102-948c-c0c712af54d0 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-34-2605 | 9335e4df-9974-47ec-84c4-256cd33522f2 | 09/02/2010 | LUSC | Prior malignancy | [intgen.org]: Prior Malignancy |
| TCGA-34-2605-01A-21-2193-20 | 79a77711-5efb-4811-9e36-c6823526a48a | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-34-2608-01A-11-2193-20 | f3b4f474-f6b9-47aa-bcf8-a06304109a51 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-34-2609 | 257650bd-2e2b-4680-b77b-f9268b3af4ee | 09/02/2010 | LUSC | Prior malignancy | [intgen.org]: Prior Malignancy |
| TCGA-34-2609-01A-21-2193-20 | ce27724e-e32d-4576-a458-17ee97966504 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-34-5231-01A-22-2194-20 | 70790e8d-ce93-491e-8b1f-f3a5b60871b5 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-34-5232-01A-22-2194-20 | df107ef1-536f-4ba9-aed3-7bed52caa45c | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-34-5234-01A-21-2194-20 | a26c5140-ea1f-4fc1-adbb-a3c8203bd19c | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-34-5236-01A-22-2194-20 | 428e8766-529c-4372-8ea0-908252cd825c | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-34-5239-01A-22-2194-20 | fc556f8e-523f-4dc1-926c-bdc0eb9debb9 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-34-5241-01A-21-2194-20 | 0140324e-7bca-4fbb-b771-73ccd1a4c15a | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-34-5927-01A-13-2194-20 | 285a2366-5d39-41d4-ba6a-36515454fcb6 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-34-5928-01A-13-2194-20 | 98d56989-dbfb-4d7a-91f5-13f9163bab5f | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-34-5929-01A-13-2194-20 | b2b7dd0b-8713-45ee-9dfe-351b895c2046 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-34-7107-01A-13-2194-20 | b00c4a7d-5025-40e5-be42-dac01b3de7fe | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-37-3789-01A-21-2193-20 | 25a5c25c-2520-4a48-8f96-4b1798af4de6 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-37-3792-01A-21-2193-20 | f7e9d4d4-3b43-4f96-aaaf-75dbc77f68d4 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-37-3915-10A-01D-1086-04 | 677f21bb-6528-4f5a-8914-b5a6255ae6ed | 07/02/2013 | LUSC | Barcode incorrect | Incorrect barcode and UUID (TCGA-37-3915-10A-01D-1086-04:677f21bb-6528-4f5a-8914-b5a6255ae6ed) replaced by correct barcode and uuid TCGA-18-4083-11A-01D-1086-04:1ee0824c-09b3-47ce-897d-627b97966809 |
| TCGA-37-4129-01A-21-2193-20 | 8db5bd89-429b-4872-9ca0-fb72e95cf504 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-37-4133-01A-21-2193-20 | 759891ff-ab70-4687-bd59-b6df4d18f93f | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-37-4135-01A-21-2193-20 | 7cdeb372-38d2-46a5-a868-cac875e0c524 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-37-4141-01A-11-2193-20 | b464e455-cab7-456b-89dc-ca193fd7a25f | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-37-5819-01A-21-2194-20 | 9218f291-efd3-41a3-a784-7934ea10fe03 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-39-5011-01A-21-2194-20 | 543782e2-71d3-4cc2-80e4-11b9a0eb15ce | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-39-5016-01A-21-2194-20 | 9d441074-5562-43c7-8158-903e11fb1eaa | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-39-5019-01A-21-2194-20 | a928f1c8-ed6b-4908-8174-03bf26fd1fa4 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-39-5021-01A-21-2194-20 | 34e208a6-3752-47a1-87f3-ae1c02612d17 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-39-5022-01A-22-2194-20 | 441d3e63-041c-48f0-bc13-9febd802aab8 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-39-5024-01A-22-2194-20 | 82c886e2-5803-46e5-9553-949321c21d34 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-39-5027-01A-22-2194-20 | 65da1c24-f058-4754-80b1-bb45247f835b | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-39-5028-01A-21-2194-20 | 424c5902-5b4c-4576-a19b-f3e7aab0ff1d | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-39-5029-01A-21-2194-20 | bcb62b1f-2852-4823-8028-9845e480e34f | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-39-5030-01A-21-2194-20 | 6bf62267-1f99-4080-ad9d-caf0f7b60b68 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-39-5031-01A-21-2194-20 | 02171381-ad60-4e7b-a56d-c0a3f129dcaa | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-39-5034-01A-21-2194-20 | 9088cd2b-f01a-4e61-949b-026e4be3479a | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-39-5035-01A-21-2194-20 | 3c25960c-f4f3-493f-8cff-b039e73b921e | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-39-5037-01A-21-2194-20 | 9864ab85-daea-4018-b513-0f577c9391f4 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-39-5039 | ffb83f21-06d9-4e52-a2d0-e85c13f4037f | 01/09/2011 | LUSC | Prior malignancy | [intgen.org]: Subject has Hx of prior malignancy |
| TCGA-39-5039 | ffb83f21-06d9-4e52-a2d0-e85c13f4037f | 11/10/2012 | LUSC | History of acceptable prior treatment related to a prior/other malignancy | Prior malignancy prostate cancer, treated with hormone therapy and locoregional radiation. |
| TCGA-39-5040-01A-11-2194-20 | d5a08f32-ad9a-45d2-8f8b-66283eafad42 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-43-2578 | 37f5457e-21d9-4b79-95d5-ded6f2e43087 | 10/31/2012 | LUSC | Prior malignancy | Prior malignancy R LUAD. No systemic chemotherapy or radiaiton. |
| TCGA-43-2578-01A-21-2193-20 | 8533dc60-fcd4-4b70-af5d-624df2d66eb2 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-43-2581-01A-21-2193-20 | 25c27349-3d97-4602-aa07-8187a7c97788 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-43-3394-01A-21-2193-20 | 16838c14-8069-48d4-b57a-f06db613503b | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-43-5668 | f5ad138c-1714-41e9-9c2d-c88050bec407 | 10/31/2012 | LUSC | Prior malignancy | Prior malignancy basal cell carcinoma of the skin. No systemic chemotherapy or radiation. |
| TCGA-43-5668-01A-21-2194-20 | e34afcb4-f3ec-4f28-b419-cf55da46f62e | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-43-5670-01A-11-2194-20 | 75fb3562-d7fc-459c-acc9-5b66d16eb7fa | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-43-6143-01A-13-2194-20 | 01f9ec9b-2018-4773-aac3-afc9218f8057 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-43-6770-01A-13-2195-20 | ebc6f011-b3ec-4c3a-b834-042da6b23280 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-43-6771-01A-13-2195-20 | 6d6d5925-f180-4866-bcb1-f954a2da17f7 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-43-7656-01A-13-2195-20 | 8f489848-549d-41e4-9a75-db8aea47589f | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-43-7657 | dbece124-c042-4adc-8136-90e7940ee6ad | 10/31/2012 | LUSC | Prior malignancy | Prior malignancy uterine cancer. No systemic chemotherapy or radiation. |
| TCGA-43-7658 | a6ec75d4-1c90-4527-bfae-aa91d2dae082 | 10/31/2012 | LUSC | Prior malignancy | Prior malignancy basal cell carcinoma of the nose. No systemic chemotherapy or radiation. |
| TCGA-43-7658-01A-13-2195-20 | 68a07bc1-8c04-4887-a120-c3efa5e439d2 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-43-A474 | ae2c650c-600b-4c58-893b-7fd73d44af47 | 07/16/2013 | LUSC | Prior malignancy | Patient had a prior skin malignancy. No systemic radiation or chemotherapy. |
| TCGA-46-6025-01A-13-2194-20 | 55f36d96-6b14-4aee-97fe-a846962e8512 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-46-6026-01A-13-2194-20 | 1f974ba9-6993-4575-8372-32673ea3fdd9 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-51-6867 | 3b195845-0050-49cb-b639-1fe85a131ebe | 10/31/2012 | LUSC | Prior malignancy | Prior malignancy cancer of the larynx treated with locoregional radiation. |
| TCGA-51-6867 | 3b195845-0050-49cb-b639-1fe85a131ebe | 11/10/2012 | LUSC | History of acceptable prior treatment related to a prior/other malignancy | Prior malignancy cancer of the larynx treated with locoregional radiation. |
| TCGA-51-6867-01A-13-2194-20 | df2fd16f-c857-4ec5-8ed8-07db1d345f50 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-52-7810-01A-13-2195-20 | 6e66e4f7-d938-4cf6-85e3-ea40f8838b95 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-52-7811-01A-13-2195-20 | feb2a011-9826-4922-8fdb-e702a929a793 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-52-7812-01A-13-2195-20 | e78b8041-fe48-46e1-b651-a19c69be92e6 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-56-5897-01A-12-2194-20 | 59c57cc0-8672-4e6d-8248-65c676f2db8b | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-56-5898-01A-12-2194-20 | f1648030-8469-478a-99e6-13ec906dca7e | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-56-6545-01A-13-2194-20 | acdc06c7-b306-4fc8-9a28-68b2a9a78d4c | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-56-6546-01A-13-2194-20 | d3df09a4-a843-49d4-84b3-e7822b797bdc | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-56-7221 | 1dba835e-cbe9-41e0-883d-50bf86bc7821 | 10/31/2012 | LUSC | Prior malignancy | Prior malignancy basal cell carcinoma of the skin. No systemic chemotherapy or radiation. |
| TCGA-56-7221-01A-13-2195-20 | ce08b9c6-00c0-45d0-b84d-f0bce0fdc469 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-56-7222-01A-13-2195-20 | 727b199a-6c1b-4d39-9e96-e983ca7ba1c9 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-56-7730-01A-13-2195-20 | 4b68ddb5-5d40-4009-8269-2262e4b2a97a | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-56-8305 | d5e94dcf-994f-48a0-b491-bbbf1c2a6783 | 10/31/2012 | LUSC | Prior malignancy | Prior malignancy B-cell chronic lymphocytic leukemia. No systemic chemotherapy or radiation. |
| TCGA-56-8308 | 399c936e-ba68-4040-98d4-917a87dad603 | 10/31/2012 | LUSC | Prior malignancy | Prior malignancy melanoma of the R eye. No systemic chemotherapy or radiation. |
| TCGA-56-8504 | 9ee64a87-7224-461c-94da-29710d73164f | 10/31/2012 | LUSC | Prior malignancy | Prior malignancy skin cancer. No systemic chemotherapy or radiation. |
| TCGA-60-2695 | acae4e48-57de-40c5-9ae5-4386144ebaea | 10/11/2010 | LUSC | Prior malignancy | [intgen.org]: Subject has Hx of prior malignancy |
| TCGA-60-2695-01A-21-2193-20 | ec5712a3-b8ad-4fad-a544-e815bffacece | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-60-2696 | bff77f70-973a-4b49-8fd9-4a767f5df2c0 | 10/11/2010 | LUSC | Prior malignancy | [intgen.org]: Subject has Hx of prior malignancy |
| TCGA-60-2696 | bff77f70-973a-4b49-8fd9-4a767f5df2c0 | 11/10/2012 | LUSC | History of unacceptable prior treatment related to a prior/other malignancy | Prior malignancy breast cancer treated w/ tamoxifen and radiation and tymus cancer treated w/ cancerrboplatin and Paclitaxel |
| TCGA-60-2696-01A-21-2193-20 | 3a198ed8-723a-4655-8fb2-74e042bea193 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-60-2697 | 3c112114-6a8b-4aea-9349-6dffbaad078d | 11/10/2012 | LUSC | Neoadjuvant therapy | Patient received neo-adjuvant vincristine, CCNU, cytoxan, doxirubicin, and cisplatinum prior to resection of TCGA tumor |
| TCGA-60-2697-01A-21-2193-20 | 7125f62c-3ad3-45a5-aa83-a9052c5669ed | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-60-2698 | fd9ee494-65fe-4de4-adff-7952a059b17f | 10/11/2010 | LUSC | Prior malignancy | [intgen.org]: Subject has Hx of prior malignancy |
| TCGA-60-2698-01A-21-2193-20 | f57a7f9b-23c2-4a93-9322-9df5bc51eb99 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-60-2703-01A-21-2193-20 | 68eb1b05-eb54-4b64-a7e5-6e76e09e6b11 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-60-2704-01A-21-2193-20 | ffb8aceb-b5f5-4722-8051-74a36e32cfe3 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-60-2706-01A-21-2193-20 | ef42af10-10c8-4c5f-92f7-aa8fec60634a | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-60-2708-01A-21-2193-20 | 64455e1c-360e-4627-8c8a-55c27c7705c3 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-60-2709-01A-22-2193-20 | 6542146d-b4b9-4ed7-9fcf-b511ad1c43d7 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-60-2710 | b28e3be1-9843-4204-b999-b3e2a909c7bd | 11/18/2011 | LUSC | Neoadjuvant therapy | [intgen.org]: Subject Positive for Neo-Adjuvant Therapy |
| TCGA-60-2710-01A-21-2193-20 | fe48e710-052c-48da-a9ba-7705e7451700 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-60-2711 | 1f11de87-a5fe-49fd-80c1-e279b2bc69de | 10/11/2010 | LUSC | Prior malignancy | [intgen.org]: Subject has Hx of prior malignancy |
| TCGA-60-2711-01A-21-2193-20 | 00a75e05-8928-432f-ae8f-3acbb88a182b | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-60-2712 | f355cd59-eaa9-46c7-ab07-b90a7afc875c | 10/11/2010 | LUSC | Prior malignancy | [intgen.org]: Subject has Hx of prior malignancy |
| TCGA-60-2712 | f355cd59-eaa9-46c7-ab07-b90a7afc875c | 11/10/2012 | LUSC | History of unacceptable prior treatment related to a prior/other malignancy | Prior malignancy L breast cancer treated w/ locoregional radiation (TCGA tumor is in L upper lobe of lung) |
| TCGA-60-2712-01A-21-2193-20 | 048d4992-bd37-46bb-97c0-7cfaf69cc61d | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-60-2713-01A-21-2193-20 | aef657e5-4555-4842-946a-7883c8f8b362 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-60-2714 | 705a4688-f10f-4e6a-aed9-6efc3b3b9989 | 11/10/2012 | LUSC | Neoadjuvant therapy | Patient received neo-adjuvant carboplatin, taxol, and cisplatin prior to resection of TCGA tumor |
| TCGA-60-2714-01A-21-2193-20 | 089deb86-da03-40f6-83c0-c6cc33a47ab3 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-60-2715 | f3e67161-1532-4b50-a9b5-0da80410c4d7 | 09/02/2010 | LUSC | Prior malignancy | [intgen.org]: Prior Malignancy |
| TCGA-60-2715 | f3e67161-1532-4b50-a9b5-0da80410c4d7 | 11/10/2012 | LUSC | History of unacceptable prior treatment related to a prior/other malignancy | Prior malignancy of the larynx treated w/ chemotherapy and radiation. |
| TCGA-60-2716-01A-21-2193-20 | b1371353-26af-4c41-b52e-dc7a0848ec98 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-60-2719-01A-21-2193-20 | 7d294b6d-9ac2-4e67-a2e0-5a7530db840c | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-60-2720-01A-21-2193-20 | 2c8e7971-12b3-4301-856d-38e55ed745d5 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-60-2721 | bcd78677-98d5-4403-8313-e1fbd76e8ef7 | 10/11/2010 | LUSC | Prior malignancy | [intgen.org]: Subject has Hx of prior malignancy |
| TCGA-60-2721-01A-21-2193-20 | d292d1eb-ee65-4573-8662-faedf11fa9ad | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-60-2724-01A-21-2193-20 | ec285ff7-4d23-4739-9946-065f534d6fe8 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-60-2725-01A-21-2193-20 | dc18de9c-9edf-48c8-9a00-3598aad84aa5 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-60-2726-01A-21-2193-20 | 49bf0bf2-031f-4d67-83a4-abc14322c298 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-63-5128-01A-21-2194-20 | c514a02d-1b88-48ad-8d47-e225eda23780 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-63-5131-01A-21-2194-20 | 494e308b-4cd4-44ac-b556-9ea1a95be212 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-63-6202-01A-13-2194-20 | 52080758-70e0-4463-8ef4-ebb8ba5e19d2 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-63-7020-01A-13-2194-20 | ff0190fb-eb34-4331-9068-2c02bf067253 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-63-7021-01A-13-2194-20 | 81db3e1a-0540-49d0-a6fa-c2561c14fe7c | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-63-7022-01A-13-2194-20 | 51130a95-5996-4288-ab16-504f6d8b8314 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-63-7023-01A-13-2194-20 | ab830587-6698-4cd1-9690-d620819ef10f | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-66-2727-01A-21-2193-20 | d494adb7-9e76-4717-b142-47521c544e9a | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-66-2737-01A-41-2193-20 | 46aec886-20f0-47f3-ba36-3ba0b036f764 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-66-2758-01A-11-2193-20 | 4dda1522-0094-4b54-b413-ad6d92df3ad9 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-66-2766-01A-21-2193-20 | ba82b423-e845-4d6f-b8bf-aa44344e0e2e | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-66-2767-01A-21-2193-20 | 2046ba58-db49-44ba-b6ae-fb9eee38a211 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-66-2768-01A-21-2193-20 | 28068872-a9b1-4e43-b5a4-92d1cdd03408 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-66-2769-01A-11-2193-20 | 5de8582a-34f9-4ea2-943d-bf46f07c06e0 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-66-2770-01A-21-2193-20 | e858ee92-0438-48e9-a70d-80ef2c0ad539 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-66-2773-01A-21-2193-20 | 1d33bdef-845d-4bf8-bc13-72113614a4c8 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-66-2777-01A-21-2193-20 | 129560c0-36c3-4f01-98ed-606e583390d4 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-66-2778-01A-11-2193-20 | f5dca0d5-550d-4107-b6ad-9d347a39afa5 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-66-2781-01A-21-2193-20 | b307a0f2-a455-4b20-b866-8da02f3d8fd4 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-66-2782-01A-21-2193-20 | 6cafe140-32f0-40b7-8d8b-60e7c76e4c0c | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-66-2783-01A-21-2193-20 | 74291822-bcab-4871-ad7c-cf2023ec7c2f | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-66-2785-01A-21-2193-20 | a8bd2e87-dee1-4801-8742-25eacf7d7484 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-66-2788-01A-21-2193-20 | c1620625-664d-4fec-9ddc-ace245378ca7 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-66-2790-01A-21-2193-20 | 03a83493-5aa7-4c60-9fb0-9d4112d0fec2 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-66-2791-01A-21-2193-20 | cd4f93c9-f2fe-4271-ab18-78e528cfb9ad | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-66-2794-01A-21-2193-20 | ab258a4f-7597-4592-81c1-9f8aa1b7bf0c | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-66-2795-01A-11-2193-20 | e145986b-e6d4-4e31-bf1e-b242af22f436 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-66-2800-01A-21-2193-20 | 46d73760-a073-4776-a709-4c8a47d0d076 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-68-7756-01A-13-2195-20 | ed06c7b1-cc32-46c2-810c-310112f4c7a8 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-68-8250 | 7b982d5e-3a7d-40ac-bd25-6044c62879b6 | 11/10/2012 | LUSC | Synchronous malignancy | Pt with synchronous R LUAD, mixed subtype and L LUSC. |
| TCGA-70-6722-01A-13-2194-20 | 7f55ab0d-c1e6-40bb-822c-a2a007f6f2aa | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-70-6723-01A-13-2194-20 | c11267c5-85c9-41fc-9d22-9531b264afa3 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-77-6842-01A-13-2194-20 | 0b3eb76b-445c-4a34-9e9c-d626c5a79b80 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-77-6843-01A-13-2194-20 | ad48f945-91c3-4ef1-8ecd-4dfbb5449718 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-77-6844-01A-13-2194-20 | 7490a6fd-28ce-444d-800c-5d8da101263e | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-77-6845-01A-13-2194-20 | 53a0c948-51c5-45f0-ae9e-a27679f2849f | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-77-7139-01A-13-2195-20 | 170fc88b-90da-456b-b2d2-b8675c357b8e | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-77-7140 | 107f6b9a-2883-4499-a40a-ec25bc834a06 | 01/24/2012 | LUSC | Prior malignancy | [intgen.org]: Patient had prior malignancy of basal cell carcinoma; treated surgically only. |
| TCGA-77-7141-01A-13-2195-20 | 0f4cb2ec-80f5-4ecf-b1fe-87862265e560 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-77-7142-01A-13-2195-20 | f8ffcd7b-8e62-42ab-a042-d9b8e2eb028e | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-77-7335-01A-13-2195-20 | cbbac7ba-2c9e-48da-a60b-d48636e498d9 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-77-7337-01A-23-2195-20 | 52200f31-4605-44ce-838c-91729bfe62fb | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-77-7338-01A-13-2195-20 | 79c97d84-243a-4530-b77f-9f1228a2217f | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-77-7463-01A-13-2195-20 | a0e4c36a-85d9-44d7-9423-307a37ab300b | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-77-7465-01A-13-2195-20 | 9cbef841-960d-477c-8e8c-96a3c7353478 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-77-8138 | 283af87a-f962-47ab-8a7b-4fcd7e45cdf6 | 10/31/2012 | LUSC | Item does not meet study protocol | Subjects history of prior malignancies is unknown, which does not meet study protocol criteria. |
| TCGA-77-A5GA | ce137f49-d12b-4112-825a-e673545f54e5 | 06/16/2014 | LUSC | History of unacceptable prior treatment related to a prior/other malignancy | unknown treatment history |
| TCGA-79-5596-01A-11-2194-20 | 7ffba9b0-d42d-4078-b1a5-f83bcb3c39e1 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-85-6175-01A-13-2194-20 | 1251f240-d00c-412d-bd87-07cffed92f72 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-85-6560-01A-13-2194-20 | e70edfac-57af-42e6-a823-2b20b8e9e203 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-85-6561-01A-13-2194-20 | 9a0f38cb-9131-4cb6-8874-853dd8c89a48 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-85-6798-01A-13-2194-20 | 8e798033-e911-4140-9060-f2bdcfddb539 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-85-7696-01A-13-2195-20 | f20b163a-ad2d-46b0-869e-f6a742d4b8ac | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-85-7697-01A-13-2195-20 | 2be75562-f756-4876-a44a-9c363f34530f | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-85-7698-01A-13-2195-20 | 4906559e-b052-4afa-863c-afa098b38d54 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-85-7699-01A-13-2195-20 | 097a545f-3da7-43fa-a441-f6417346ecb5 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-85-7710-01A-13-2195-20 | d8a44db0-50c4-4f6e-bae7-6d42afa90554 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-85-7843-01A-13-2195-20 | 777f34fc-0425-4901-a25e-8f841fa64f26 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-85-7844-01A-13-2195-20 | 8e02f3ec-c4a3-447b-b2f3-c215bd907ac7 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-85-7950-01A-13-2195-20 | a454299d-b074-4dd9-adf3-3e48f4473543 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-90-6837-01A-13-2194-20 | 56eec851-cabd-46ab-af62-812dae018005 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-90-7766 | 3fdf941e-40ec-43b6-b6e3-31a0861bd5b8 | 10/31/2012 | LUSC | Prior malignancy | Prior malignancy of a gynecological cancer. No systemic chemotherapy or radiation. |
| TCGA-90-7766-01A-23-2195-20 | dd8497bc-44e4-4128-80b0-64b3ca838c64 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-90-7767-01A-13-2195-20 | 4a4135f8-825b-457a-a65c-edf07e0215cb | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-90-7769-01A-13-2195-20 | 71d2cccb-ba7a-47f2-96d0-11b7b3f0c20f | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-90-7964 | 6e6b8596-76aa-49f5-a997-46ebc0e43934 | 11/10/2012 | LUSC | Synchronous malignancy | Pt with synchronous R LUAD. |
| TCGA-92-7340-01A-23-2195-20 | bbdcf945-baf7-42ed-ab05-6f2dcb81c323 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-94-7033 | 3351b902-9b7e-4b90-bf6b-bcf74be00bc1 | 10/31/2012 | LUSC | Prior malignancy | Prior malignancy bladder cancer treated with locoregional intravesical therapy |
| TCGA-94-7033 | 3351b902-9b7e-4b90-bf6b-bcf74be00bc1 | 11/10/2012 | LUSC | History of acceptable prior treatment related to a prior/other malignancy | Prior malignancy bladder cancer treated with locoregional intravesical therapy |
| TCGA-94-7033-01A-13-2194-20 | 95f1fbdc-e59b-4825-b63e-c71b23b2f6e9 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-94-7557 | ea741488-5475-4a3d-b9fe-81722f129974 | 10/31/2012 | LUSC | Prior malignancy | Prior malignancy prostate cancer. No systemic chemotherapy or radiation. Patient with synchronous LUAD, mixed subtype. |
| TCGA-94-7557 | ea741488-5475-4a3d-b9fe-81722f129974 | 11/10/2012 | LUSC | Synchronous malignancy | Prior malignancy prostate cancer. No systemic chemotherapy or radiation. Patient with synchronous LUAD, mixed subtype. |
| TCGA-94-7557-01A-13-2195-20 | b55c5cd9-2ac9-4b08-bebd-acd943bf9521 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-94-7943 | aecf85cc-058c-46f3-9cdc-3573ac3b8438 | 10/31/2012 | LUSC | Prior malignancy | Prior malignancy lung cancer. No systemic chemotherapy or radiation. |
| TCGA-94-7943-01A-13-2195-20 | 78584fca-e293-47bf-b2a0-bcaa476544a7 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-96-7544-01A-13-2195-20 | f2806a36-bdd6-48dc-9c91-c5eddff6a4ec | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-96-7545 | 4ca13c92-84b4-4edf-842a-b20b7e713415 | 10/31/2012 | LUSC | Prior malignancy | Prior malignancy bilateral LUAD. Prior malignancy R LUAD. No systemic chemotherapy or radiation. |
| TCGA-96-A4JK | 613adbb3-c2d1-4992-9953-c4fadd249001 | 08/14/2014 | LUSC | History of unacceptable prior treatment related to a prior/other malignancy | Patient was given BCG for the prior bladder cancer, which was not approved by the lung group as an acceptable prior treatment. (per Kristen Leraas/BCR TCGA-2222) |
| TCGA-98-7454-01A-13-2195-20 | fed5fc80-909c-45a8-a5d1-06c865837c32 | 03/12/2012 | LUSC | Item is noncanonical | LUSC Proteomics MDA |
| TCGA-98-8020 | ffb53b81-c1ed-473c-bdcd-b325b02e22ae | 10/31/2012 | LUSC | Prior malignancy | Prior malignancy bladder cancer. No systemic chemotherapy or radiation. |
| TCGA-J1-A4AH | 99daa971-31d0-4c37-9c12-b0dc42ddd19b | 07/16/2013 | LUSC | Synchronous malignancy | Patient was diagnosed with a thymoma at same time as this lung mallignancy. |
| TCGA-NK-A5D1 | 80aa8e99-41d5-422f-a1bb-69599aa8236f | 06/16/2014 | LUSC | History of unacceptable prior treatment related to a prior/other malignancy | systemic treatment given to the prior/other malignancy |